Digital Health Interventions by Clinical Pharmacists: A Systematic Review

Taehwan Park, Jagannath Muzumdar and Hyemin Kim
Additional contact information
Taehwan Park: Pharmacy Administration and Public Health, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA
Jagannath Muzumdar: Pharmacy Administration and Public Health, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA
Hyemin Kim: College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA

IJERPH, 2022, vol. 19, issue 1, 1-18

Abstract: Integrating digital interventions in healthcare has gained increasing popularity among clinical pharmacists (CPs) due to advances in technology. The purpose of this study was to systematically review CP-led digital interventions to improve patients’ health-related clinical outcomes. PubMed and the Cochrane Database were searched to select studies that had conducted a randomized controlled trial to evaluate clinical outcomes in adults following a CP-led digital intervention for the period from January 2005 to August 2021. A total of 19 studies were included in our analysis. In these 19 studies, the most commonly used digital intervention by CPs was telephone use ( n = 15), followed by a web-based tool ( n = 2) and a mobile app ( n = 2). These interventions were provided to serve a wide range of purposes in patients’ outcomes: change in lab values (e.g., blood pressure, HbA1c) ( n = 23), reduction in health service use ( n = 8), enhancing adherence ( n = 6), improvement in drug-related outcomes ( n = 6), increase in survival ( n = 3), and reduction in health-related risk (e.g., CVD risk) ( n = 2). Although the impacts of telephone-based interventions on patients’ outcomes were decidedly mixed, web-based interventions and mobile apps exerted generally positive influences. To date, little research has investigated the cost-effectiveness of digital interventions. Future studies are warranted.

Keywords: clinical pharmacists; digital interventions; patient outcomes; randomized controlled trials (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/1/532/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/1/532/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:1:p:532-:d:717245

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().